Affiliation:
1. Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China
Abstract
Chronic kidney disease (CKD) is characterized by persistent kidney dysfunction, ultimately resulting in end-stage renal disease (ESRD). Renal fibrosis is a crucial pathological feature of CKD and ESRD. However, there is no effective treatment for this condition. Despite the complex molecular mechanisms involved in renal fibrosis, increasing evidence highlights the crucial role of histone modification in its regulation. The reversibility of histone modifications offers promising avenues for therapeutic strategies to block or reverse renal fibrosis. Therefore, a comprehensive understanding of the regulatory implications of histone modifications in fibrosis may provide novel insights into more effective and safer therapeutic approaches. This review highlights the regulatory mechanisms and recent advances in histone modifications in renal fibrosis, particularly histone methylation and histone acetylation. The aim is to explore the potential of histone modifications as targets for treating renal fibrosis.
Funder
National Natural Science Foundation of China
Reference138 articles.
1. Chronic Kidney Disease Diagnosis and Management: A Review;Chen;JAMA,2019
2. GBD Chronic Kidney Disease Collaboration (2020). Global, Regional, and National Burden of Chronic Kidney Disease, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet, 395, 709–733.
3. Forecasting Life Expectancy, Years of Life Lost, and All-Cause and Cause-Specific Mortality for 250 Causes of Death: Reference and Alternative Scenarios for 2016–40 for 195 Countries and Territories;Foreman;Lancet,2018
4. Cognitive Impairment in Ckd: Pathophysiology, Management, and Prevention;Drew;Am. J. Kidney Dis.,2019
5. Patient-Centred Approaches for the Management of Unpleasant Symptoms in Kidney Disease;Lockwood;Nat. Rev. Nephrol.,2022